| Mrs Jennifer Lee Ruff, | |
|
290 N Wayte Ln, Fresno, CA 93701-2124 | |
| (559) 459-5700 | |
| Not Available |
| Full Name | Mrs Jennifer Lee Ruff |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 290 N Wayte Ln, Fresno, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023287281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY22474 (California) | Secondary |
| 101YM0800X | Counselor - Mental Health | PSY22474 (California) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
The Republican lawmaker who will take the chair of the House's main investigative committee has made clear his interest in examining the overuse of expensive medical procedures while a newly tapped GOP subcommittee chief pledges to "dismantle Obamacare." Meanwhile, the food safety bill has been folded into must-pass legislation to fund the U.S. government.
The biological complexity of cancer and other diseases demands a more formidable arsenal of therapies than currently available. Most therapeutic approaches ignore the dynamic molecular network of genes, targeting instead only very few selected disease-related genes.
Instrumentation Laboratory today announced the commercialization in Europe of their HemosIL Direct Thrombin Inhibitor (DTI) Assay. When used in conjunction with HemosIL Dabigatran Calibrators and Controls, this test offers an automated solution for the measurement of dabigatran, a direct oral anticoagulant (DOAC).
New technology now makes it possible to collect 'near real-time' data about whether people are having any side effects from vaccination. By studying people who received the 2009-10 swine flu vaccination in Scotland, researchers showed that this rapid reporting can add another layer of safety to future vaccination campaigns. In addition, the data collected revealed no significant safety issues in patients exposed to the vaccine.
Merck & Co., Inc. announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) supports the permissive use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for boys and young men ages 9 to 26, which means that GARDASIL may be given to males ages 9 to 26 to reduce the likelihood of acquiring genital warts at the discretion of the patient's health care provider.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Lee Ruff, 4910 E Clinton Way, Suite 101, Fresno, CA 93727-1560 Ph: (559) 443-2682 | Mrs Jennifer Lee Ruff, 290 N Wayte Ln, Fresno, CA 93701-2124 Ph: (559) 459-5700 |
News Archive
The Republican lawmaker who will take the chair of the House's main investigative committee has made clear his interest in examining the overuse of expensive medical procedures while a newly tapped GOP subcommittee chief pledges to "dismantle Obamacare." Meanwhile, the food safety bill has been folded into must-pass legislation to fund the U.S. government.
The biological complexity of cancer and other diseases demands a more formidable arsenal of therapies than currently available. Most therapeutic approaches ignore the dynamic molecular network of genes, targeting instead only very few selected disease-related genes.
Instrumentation Laboratory today announced the commercialization in Europe of their HemosIL Direct Thrombin Inhibitor (DTI) Assay. When used in conjunction with HemosIL Dabigatran Calibrators and Controls, this test offers an automated solution for the measurement of dabigatran, a direct oral anticoagulant (DOAC).
New technology now makes it possible to collect 'near real-time' data about whether people are having any side effects from vaccination. By studying people who received the 2009-10 swine flu vaccination in Scotland, researchers showed that this rapid reporting can add another layer of safety to future vaccination campaigns. In addition, the data collected revealed no significant safety issues in patients exposed to the vaccine.
Merck & Co., Inc. announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) supports the permissive use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for boys and young men ages 9 to 26, which means that GARDASIL may be given to males ages 9 to 26 to reduce the likelihood of acquiring genital warts at the discretion of the patient's health care provider.
› Verified 5 days ago